10 Kojima M，Shiojima I, yamazaki T, et al. Angiotensin Ⅱ re ceptor antagonist TCV-116 induces regression of hypertensive left ventricular h ypertrophy in vivo and inhibits the intracellular signaling pathway of stret ch-mediated cardiomyocyte hypertrophy in vitro. Circulation,1994,89(5):2204
11 Haddad F, Bodell P W, Mccue S A, et al. Food restriction-induc ed transformation in cardiac functional and biochemical properties in rats. J Ap pl physiol,1993,74(2):606
12 Swoap S J, Haddad F, Bodell P, et al. Control of β-myosin heavy chain expression in systemic hypertension and caloric restriction in the rat he art. am J Physiol,1995,269(4 Pt 1):1025
13 Morris G S, Herrick R E, Balduin K M. Dietary carbohydrates modify ca rdiac myosin isoenzyme profiles of semistarved rats. Am J Physiol,1989,256(Regul atory integrative Comp Physiol 25):976
14 Swoap S J, Haddad F, Bodell P, et al. Effect of chronic energy d eprivation on cardiac thyroid hormone receptor and myosin isoform expression. Am J physiol,1994,166(Endocrinol. Metab.29):254
15 Pissarek M, Bigard X, Mateo P, et al. Adaptation of cardiac myo sin and creatine kinase to chronic hypoxia: role of anorexia and hypertension Am J physiol,1997,272(4 pt 2):1690
16 Malhotra A, Sanghi V. Regulation of contractile proteins in diabetic h eart. cardiovasc Res,1997,34(1):34
17 Rosen P, Pogatsa G, Tachope D, et al. Diabetic cardiomyopathy: pat hophysiologic concepts and therapeutic approaches. Klin Wochenschr,1992,69(Suppl29):3
18 Afzal N, Pierce G N, Elimban V, et al. Influence of verapamil on s ome subcellular defects in diabetic cardiomyopathy. Am J Physiol,1989,256(4 Pt 1):453
19 Pierce G N, Dhalla N S. Cardiac myofibrillar ATPase activity in diabet ic rats. J Mol Cell Cardiol,1981,13(12):1063
20 Rupp H, Elimban V, Dhalla N S. Diabetes-like action of intermittent f asting on sarcoplasmic reticulum Ca2+-pump ATPase and myosin isoenzymes c an be prevented by sucrose. Biochem Biophy Res commun.1989,164(1):319
21 Pagani E D, Alonsi A A, Grant A M, et al. Changes in myofibrillar content and Mg2+-ATPase activity in ventri-cular tissues from pa tients with heart failure caused by coronary artery disease,cardiomyopathy,or mi tral valve insufficiency. Circ Res,1998,63(2):380
22 Ebashi S, Nonomura Y, Kohama K, et al. Regulation of muscle contra ction by ca ion. Mol Biol Biochem Biophys,1980,32:183
23 Malhotra A, Lopez C, Nakouzi A. Troponin subunits contribute to altere d myosin ATPase activity in diabetic cardiomyopathy. Mol Cell Biochem,1995,151(2):165
24 Gwathmey J K, Hajjar R T. Calcium-activated force in a turkey model o f spontaneous dilated cardiomyopathy. J Mol Cell Cardiol,1992,24(12):1459
25 Noland T A Jr, Kuo J F. Phosphorylation of cardiac myosin light chain 2 by protein kinase C and myosin light chain kinase increases Ca2+-stimul ated actomyosin Mg2+-ATPase activity. Biochem Biophys Res commun,1993,193 (1):254
26 Mylotte K M, Cody V, Davis P, et al. Milrinone and thyroid hormone stimulate myocardial membrane Ca2+-ATPase activity and share structural homologies. Proc Natl Acad Sci USA,1985,82(23):7974
27 Umeda P K, Levin J E, Sinha A M, et al. Molecular anatomy of cardi ac myosin he avy chain genes. In:Emerson C, Fischman D, Nadal-Ginard B, et al, eds. m olecular biology of muscle development, UCLA Symposium on Molecular and cellular Biology New Series,1986,vol.29. New York, Alan R Liss,808
28 Mohr-kahalys, kahaly G, Meyer J: Cardiovascular effects of thyroid ho rmones. Z Kardiol,1996,85(6):219
29 Rohrer D K, Mestril R, Sayen R, et al. Thyroid hormone induced in creases in rat heart sarcoplasmic reticulum Ca2+ ATP are transcriptionally mediated an d require serum factors. Endocrinology,1989,122(suppl):T-87
